Pharmetheus at ASCPT
We will be attending ASCPT 2026 in Denver, March 4–6. Visit our poster session or join our MIDD session to discuss the latest in Model-Informed Drug Development.
Scientific contributions
The draft ICH M15 guidelines provide a framework for the general principles of Model-Informed Drug Development (MIDD). For teams working toward regulatory milestones, the focus now shifts to practical implementation: how to best prepare and present model-based evidence to support decision-making.
In this learning lab event, Martin Bergstrand and Emma Hansson will share perspectives on the current application of MIDD in regulatory settings. The session will cover:
- Practical considerations for putting the ICH M15 guidelines into action.
- Strategies for planning and preparing MIDD evidence for regulatory review.
- Examples of real-world cases with high regulatory impact.
Friday March 6, 2026
12.00 PM -1.00 PM
